Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureLaura E. Davis, Spyridon P. Basourakos, Adam C. Calaway
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Twelve-month results from the CISTO study comparing radical cystectomy versus bladder-sparing therapy for recurrent high-grade non-muscle-invasive bladder cancer
10.1200/jco-25-01324 · 2026
Mechanisms, clinical trials, and new treatments for BCG-unresponsive in nonmuscle invasive bladder cancer
10.1002/cam4.71243 · 2025
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
10.1016/s1470-2045(24)00178-5 · 2024
The financial burden of localized and metastatic bladder
10.1016/j.eururo.2024.12.002 · 2025
Systematic review of the therapeutic efficacy of bladder-preserving treatments for non-muscle-invasive bladder cancer following intravesical bacillus Calmette-Guérin
10.1016/j.eururo.2020.02.012 · 2020
No additional external references are available.